Evaluation of Breast Cancer Subtypes Based on ER/PR and Her2 Expression: A Clinicopathologic Study of Hormone Receptor Status (ER/PR/HER2-neu) in Breast Cancer. Faridpur Med Coll J. 2020;14(1):8-12. doi:10.3329/fmcj.v14i1.46158